CDKN2A and pituitary gland adenoma: Reduced levels of the INK4 family members of cyclin-dependent kinase inhibitors, p15Ink4b, p16Ink4a, and p18Ink4c in pituitary adenomas appear to be caused mainly by promoter hypermethylation (54–57).